Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points.

@article{Puig2014EfficacyOB,
  title={Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points.},
  author={Llu{\'i}s Puig and Antonia Lorenzo Lopez and Eva Vilarrasa and Isabel Beristain Garc{\'i}a},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2014},
  volume={28 12},
  pages={
          1633-53
        }
}
BACKGROUND Differences in response rates of biologics for the treatment of moderate-to-severe plaque psoriasis have been reported in several meta-analyses published to date. However, the usefulness of these meta-analyses is limited as they do not reflect currently approved recommendations in the Summaries of Product Characteristics (SmPCs) and clinical practice. OBJECTIVE To estimate the efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis in the currently approved… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis

  • C andiz, A Garc ıa, AJ Blasco, P. L azaro
  • J Eur Acad Dermatol Venereol
  • 2012

therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment

  • VW, S Ringold, EB. Devine
  • J Eur Acad Dermatol Venereol
  • 2012

Similar Papers

Loading similar papers…